Taro Pharmaceuticals (Israel)
Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer that was publicly listed in the New York Stock Exchange before it was acquired by Sun Pharma. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Taro Pharmaceuticals (Israel), Israel, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
64%
Total
Publications
61
Total Open
Publications
39
Total
Citations
2.7K
Open Access
Percentage
64%
Total
Publications
61
Total Open
Publications
39
Total
Citations
2.7K
Breakdown
Publisher Open
40%
Both
24%
Other Platform Open
1%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
15
Hybrid 12%
5
No Guarantees 50%
20
Other Platform Open
Domain 100%
16
Institution 50%
8
Other Internet 19%
3
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 16 |
doaj.org OAI-PMH Repository | Institution | 8 |
Unknown Repository | Other Internet | 3 |
Europe PMC | Domain | 1 |